Extended-Release RANCAD in the Patients With Stable Angina Pectoris
Status:
Completed
Trial end date:
2016-12-01
Target enrollment:
Participant gender:
Summary
A double-blind, randomized, placebo-controlled, parallel study to evaluate the effects of
add-on RANCAD on exercise tolerance and angina frequency in patients with stable angina
pectoris.